Aspiration and Biopsy Needles Market to reach at USD 1,272 Million by 2024

1. Aspiration and Biopsy Needles Market to reach at USD 1,272 Million by 2024 The aspiration and biopsy needles market is projected to reach USD 1,272 million by 2024 from USD 894 million in 2019, at a CAGR of 7.3%. Rising prevalence of cancer, increasing preference for minimally invasive procedures, and cancer awareness initiatives by governments and global health organizations are the major factors driving the growth of the aspiration and biopsy needles market. In this report, the Aspiration and Biopsy Needles market has been segmented based on product type, by site, procedure, end user, and region. Download a FREE Pdf Brochuer@:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=71036825

2. What the Market Looks Like? The Report “Aspiration & Biopsy Needles Market by Product (Fine-needle Aspiration, Biopsy (Core & Vacuum Assisted)), Site, Procedure (Image-guided (Ultrasound, MRI, Stereotactic), Nonimage-guided), Enduser (Hospital, Academia) - Global Forecast to 2024” Biopsy needles accounted for the largest share of the aspiration and biopsy needles market, by product, in 2018. On the basis of product, the aspiration and biopsy needles market is segmented into aspiration and biopsy needles. The biopsy needles segment accounted for the largest share of the aspiration and biopsy needles market in 2018 due to its widespread adoption in healthcare facilities. This segment is also expected to grow at the highest rate during the forecast period. The lung segment is expected to register the highest growth rate in the aspiration and biopsy needles market during the forecast period by site, in 2019 On the basis of site, the aspiration and biopsy needles market is segmented into breast, lung, colorectal, prostate, kidney, and bone & bone marrow. The lung segment is expected to register the highest growth rate due to the increasing prevalence of lung cancer. The Major Players Opearting in the Aspiration and Biopsy Needles Market: Key players in the Aspiration and Biopsy Needles Market include CONMED Corporation (US), Medtronic Plc (Ireland), Olympus (Japan), Becton, Dickinson and Company (US), Boston Scientific Corporation (US), Cook Group Incorporated (US), Argon Medical Devices, Inc (US), INRAD Inc. (US), Somatex Medical Technologies (Germany), Stryker Corporation (US), Cardinal Health (US), Remington Medical (US), HAKKO CO.,LTD (Japan), and Merit Medical Systems (US) Get a FREE Request Sample Report@:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=71036825 Geographical Detailed Analysis for Aspiration and Biopsy Needles Market: North America held the largest share of the aspiration and biopsy needles market in 2019 The large share of the North American market can mainly be attributed to the increasing number of surgical procedures, technological advancements, rising demand for minimally invasive procedures, favorable reimbursement scenario, and rising government concerns regarding the health hazards of surgical plumes.

3. Recent Developments Product Launches and Approvals In September 2018, Olympus (Japan) received FDA approval for its EZ Shot Plus 25 G needle In April 2016, Olympus (Japan) launched aspiration biopsy needles with Side Port - Reusable (NA-2C-1) In November 2015, Cook Group (US) Incorporated launched EchoTip ProCore 20 Gage Needle for ultrasound-guided fine needle biopsy (FNB) Acquisitions In January 2019, IZI Medical Products acquired Cook Medical’s soft tissue biopsy and breast localization needle product line. In February 2018, Merit Medical Systems, Inc. announced the closure of its purchase of divestment assets from BD (Becton, Dickinson and Company) About MarketsandMarkets™: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

4. MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. Contact: Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: 1-888-600-6441 Email: sales@marketsandmarkets.com